NCT04836455

Brief Summary

The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the repeated exposures to ads that people have in the real world. This study addresses this issue by repeatedly exposing participants to vaping prevention ads over time. Participants will be adolescents aged 13-17 who currently vape or who are susceptible to vaping. Participants will be randomly assigned to ad stimuli. They will be assigned to one of two The Real Cost trial arms-health harms or addiction-or to a control trial arm (probability of assignment is 1/3 for all trial arms). Participants in the study will take 4 online surveys over a 3-week period, once per week (At week 0, 1, 2, and 3). All participants will view randomized ad stimuli based on their trial arm and answer surveys items at each session.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,565

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

July 3, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2021

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

April 24, 2024

Completed
Last Updated

April 24, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

April 5, 2021

Results QC Date

January 30, 2024

Last Update Submit

March 31, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Susceptibility to Vaping Score

    The 3-item Susceptibility to Vaping Scale assesses the extent to which adolescents are open to vaping, using a 1 to 4 response option scale. Here, 1 indicates the lowest susceptibility to vaping, and 4 represents the highest, with higher values indicating a greater susceptibility to vaping - essentially, a worse outcome. The overall scale score is determined by averaging the scores of the three items, summing these scores and dividing by 3. This method results in a score range from a minimum of 1 to a maximum of 4.

    Week 3

Secondary Outcomes (13)

  • Mean Attention Score

    Week 2

  • Mean Negative Affect Score

    Week 2

  • Mean Cognitive Elaboration Score

    Week 3

  • Mean Social Interactions Score

    Week 3

  • Mean Vaping Health Harm Risk Beliefs Score

    Week 3

  • +8 more secondary outcomes

Other Outcomes (8)

  • Mean Perceived Message Effectiveness Score (UNC Youth Scale)

    Week 2

  • Mean Perceived Message Effectiveness Score (FDA Scale)

    Week 2

  • Mean Avoidance Score

    Week 2

  • +5 more other outcomes

Study Arms (3)

The Real Cost vaping prevention ads - Health effects theme

EXPERIMENTAL
Behavioral: The FDA's The REal Cost vaping prevention ads - Health harms theme

The Real Cost vaping prevention ads - Addiction theme

EXPERIMENTAL
Behavioral: The FDA's The Real Cost vaping prevention ads - Addiction theme

Neutral vaping ads

OTHER
Behavioral: Neutral vaping ads

Interventions

Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about the health harms of vaping will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.

The Real Cost vaping prevention ads - Health effects theme

Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about vaping addiction will be shown to participants at week 0, 1, and 2. Ads will be shown in a random order.

The Real Cost vaping prevention ads - Addiction theme

Three neutral (i.e., purely informational and without graphics) vaping video ads developed by the Investigators will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.

Neutral vaping ads

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Between ages 13-17 years old
  • Be able to read and speak English
  • Be able to take an online survey in English
  • Be susceptible to vaping

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (2)

  • Kieu T, Ma H, Rohde JA, Gottfredson O'Shea N, Hall MG, Brewer NT, Noar SM. Understanding Potential Mechanisms of Vaping Prevention Messages: A Mediation Analysis of the Real Cost Campaign Advertisements. Health Educ Behav. 2025 Feb;52(1):102-112. doi: 10.1177/10901981241278565. Epub 2024 Sep 29.

  • Noar SM, Gottfredson NC, Kieu T, Rohde JA, Hall MG, Ma H, Fendinger NJ, Brewer NT. Impact of Vaping Prevention Advertisements on US Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2022 Oct 3;5(10):e2236370. doi: 10.1001/jamanetworkopen.2022.36370.

MeSH Terms

Conditions

Vaping

Condition Hierarchy (Ancestors)

SmokingBehavior

Results Point of Contact

Title
Dr. Seth M. Noar
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Seth Noar, PhD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2021

First Posted

April 8, 2021

Study Start

July 3, 2021

Primary Completion

November 3, 2021

Study Completion

November 3, 2021

Last Updated

April 24, 2024

Results First Posted

April 24, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
9 to 36 months following publication
Access Criteria
Investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.

Locations